A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.

Thomas C Heineman; Mark Schleiss; David I Bernstein; Richard R Spaete; Lihan Yan; Greg Duke; Mark Prichard; Zhaoti Wang; Qing Yan; Margaret A Sharp

doi:10.1086/503365

A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.

Identifier:nobleid.org/w1/20260515/3ABDF4EE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3ABDF4EE.svg?ark=w1%2F20260515%2F3ABDF4EE)](https://nobleid.org/work/w1/20260515/3ABDF4EE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.

Identifier:nobleid.org/w1/20260515/3ABDF4EE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3ABDF4EE.svg?ark=w1%2F20260515%2F3ABDF4EE)](https://nobleid.org/work/w1/20260515/3ABDF4EE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work